Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
about
PCSK9 inhibition: the dawn of a new age in cholesterol lowering?Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.PCSK9 and carbohydrate metabolism: A double-edged sword.Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.Effects of Evolocumab on Cardiovascular Events.A safety evaluation of evolocumab.Alirocumab versus usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial.Unexplained reciprocal regulation of diabetes and lipoproteins.
P2860
Q39057046-A2DCB00A-AA40-42B9-A474-2821FC0FE034Q39458225-3E47DD8A-8FD7-4193-8B26-B9C199F09F18Q42333207-8E7D2ECC-C745-4122-AB8C-ABBD913D7860Q44847105-6489CFF5-B5A5-4B4C-94CC-198CF8CD4560Q46165468-B90460F4-34FB-4F44-B6C0-6EF2839FADA6Q47681415-822AA8D4-D1FC-495E-8F68-AE2BE289C85EQ50047295-FC2B3C20-F702-4418-B6F7-28023B13ED52Q53690107-F97A46D8-7D08-42B1-86F3-41F7A95F53E5
P2860
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Evaluation of the efficacy, sa ...... status and metabolic syndrome.
@en
Evaluation of the efficacy, sa ...... status and metabolic syndrome.
@nl
type
label
Evaluation of the efficacy, sa ...... status and metabolic syndrome.
@en
Evaluation of the efficacy, sa ...... status and metabolic syndrome.
@nl
prefLabel
Evaluation of the efficacy, sa ...... status and metabolic syndrome.
@en
Evaluation of the efficacy, sa ...... status and metabolic syndrome.
@nl
P2093
P2860
P356
P1476
Evaluation of the efficacy, sa ...... status and metabolic syndrome
@en
P2093
C Stephen Djedjos
Christie M Ballantyne
Dirk J Blom
Maria Laura Monsalvo
Mary Elliott
Michael J Koren
Patric Nelson
Scott M Wasserman
P2860
P304
P356
10.1111/DOM.12788
P50
P577
2016-10-14T00:00:00Z